0HTG Stock Overview
Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 4/6 |
Past Performance | 2/6 |
Financial Health | 2/6 |
Dividends | 4/6 |
Cardinal Health, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$104.00 |
52 Week High | US$116.08 |
52 Week Low | US$78.10 |
Beta | 0.70 |
1 Month Change | -6.73% |
3 Month Change | -0.50% |
1 Year Change | 28.55% |
3 Year Change | 74.40% |
5 Year Change | 123.03% |
Change since IPO | 38.72% |
Recent News & Updates
Recent updates
Shareholder Returns
0HTG | GB Healthcare | GB Market | |
---|---|---|---|
7D | -3.1% | 1.9% | -0.9% |
1Y | 28.6% | -29.5% | -1.8% |
Return vs Industry: 0HTG exceeded the UK Healthcare industry which returned -29.5% over the past year.
Return vs Market: 0HTG exceeded the UK Market which returned -1.8% over the past year.
Price Volatility
0HTG volatility | |
---|---|
0HTG Average Weekly Movement | 3.2% |
Healthcare Industry Average Movement | 7.4% |
Market Average Movement | 4.8% |
10% most volatile stocks in GB Market | 11.3% |
10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0HTG has not had significant price volatility in the past 3 months.
Volatility Over Time: 0HTG's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1979 | 47,520 | Jason Hollar | www.cardinalhealth.com |
Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical.
Cardinal Health, Inc. Fundamentals Summary
0HTG fundamental statistics | |
---|---|
Market cap | US$25.01b |
Earnings (TTM) | US$639.00m |
Revenue (TTM) | US$216.15b |
39.1x
P/E Ratio0.1x
P/S RatioIs 0HTG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
0HTG income statement (TTM) | |
---|---|
Revenue | US$216.15b |
Cost of Revenue | US$208.92b |
Gross Profit | US$7.23b |
Other Expenses | US$6.59b |
Earnings | US$639.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 02, 2024
Earnings per share (EPS) | 2.63 |
Gross Margin | 3.34% |
Net Profit Margin | 0.30% |
Debt/Equity Ratio | -137.0% |
How did 0HTG perform over the long term?
See historical performance and comparison